Patients with type 2 diabetes and their clinicians may not share the same priorities when it comes to choosing a second-line drug after metformin, new research suggested.
CU Anschutz
Academic Office One
12631 East 17th Avenue
8601
Aurora, CO 80045
Are You Giving Your Patients With T2D the Meds They Want?
Default sub title
minute read
by Medscape | February 5, 2024
